RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Bone Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 109 pages - $1,000
Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
Mar 2008 - 100 pages - $3,800
Testicular Cancer - Pipeline Review, Q2 2011
Apr 2011 - 105 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Therapeutic target
Oncology del
Bone cancer del
Year
2001 del

Browse By

Industry sector
Bioinformatics
Combinatorial biology
Combinatorial chemistry
Drug research platforms
Genomics
High throughput screening
Proteomics
Therapeutic target
Chondrosarcoma
Ewings Sarcoma
Osteosarcoma
Spindle sarcoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us